WORCESTER BUSINESS JOURNAL – Marlborough-based GE Healthcare Life Sciences has signed a research and development and distribution partnership with a Kentucky health software and equipment company with a goal of personalizing tissue regeneration.
The partnership will combine products of both of the companies: GE’s IN Cell Analyzer, an imaging platform, and Advanced Solutions Life Sciences’ BioAssemblyBot, which can print manufactured tissue in three dimensions.
Biopharmaceutical companies today test their drugs in two-dimension models, the companies said. But precise 3D models provide a more physiologically relevant environment for drug testing because they mimic human reactions.
Read the full article by Grant Welker here.